AstraZeneca sells migraine drug for up to 302 million dollar Ruby Khatun Khatun8 Jun 2017 1:23 PM ISTAstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's...
AbbVie's rheumatoid arthritis drug succeeds in trial Ruby Khatun Khatun8 Jun 2017 9:27 AM ISTAbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to...
Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs Ruby Khatun Khatun7 Jun 2017 1:33 PM ISTDrug firm Alembic Pharmaceuticals is looking at filing 100 abbreviated new drug applications with the US health regulator over the next three years...
Dr Reddy's Laboratories Announces Launch of Bivalirudin for Injection in US Market Ruby Khatun Khatun7 Jun 2017 1:32 PM ISTHyderabad & Princeton: Dr. Reddy’s Laboratories Ltd. announced that it has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic...
Unichem Lab gets EIR from USFDA for Ghaziabad formulation unit Ruby Khatun Khatun7 Jun 2017 1:32 PM ISTDrug firm Unichem Laboratories said it has received an establishment inspection report from the US health regulator for its formulation manufacturing...
Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy Ruby Khatun Khatun7 Jun 2017 1:32 PM ISTNEW YORK: Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis, the company’s...
Pfizer drug delays lung cancer growth longer than Astra's Iressa-study Ruby Khatun Khatun7 Jun 2017 9:08 AM ISTA targeted drug being developed by Pfizer Inc held advanced lung cancer in check longer than AstraZeneca's Iressa in newly diagnosed patients, but...
Cadila Healthcare gets EIR from USFDA for Baddi facility Ruby Khatun Khatun6 Jun 2017 12:14 PM ISTNew Delhi: Drug firm Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its Baddi facility in...
Zydus Cadila gets USFDA nod for anti-depressant Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulator’s nod to market Mirtazapine orally disintegrating tablets, an anti-depressant,...
Bristol-Myers Squibb Announces New Collaboration to Evaluate Combination Therapy in Colorectal Cancer Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTNEW YORK: Bristol-Myers Squibb Company announced it has entered into a clinical research collaboration with Novartis to investigate the safety,...
Bharat Biotech's chikungunya vaccine enters clinical trials Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTHyderabad: Bharat Biotech said that the phase 1 human clinical trials of the indigenously developed chikungunya (CHIKV) vaccine is underway in India...
Roche combo of breast cancer drugs shows modest benefit Ruby Khatun Khatun6 Jun 2017 12:12 PM ISTCHICAGO: A clinical trial from Roche Holding AG combining the company's newer targeted drug for breast cancer with an older treatment resulted in a...
